Amyloidosis: open trials in Belgium

13 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Hopital Erasme, Anderlecht · Az St-Jan Brugge-Oostende A.V., Brugge · Antwerp University Hospital, Edegem · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège
Registry updated 2026-11-04
NCT05652335
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Antwerp University Hospital, Edegem · Universitair Ziekenhuis Gent, Gent · CHU de Liège, Liège
Registry updated 2026-11-03
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Aalst · Anderlecht · Dendermonde · Ghent · Hasselt · Leuven · Liège · Roeselare
Registry updated 2026-10-21
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Trial Treatment · Phase 3 · Novo Nordisk A/S
AZORG Ziekenhuis, Aalst · Az Middelheim, Antwerp · Algemeen Ziekenhuis Sint-Jan, Bruges · Hopital Universitaire de Bruxelles/ Academisch Ziekenhuis Brussel, Brussels · Ziekenhuis Oost-Limburg (ZOL), Genk · Universitair Ziekenhuis Brussel, Jette · Universitair Ziekenhuis Leuven, Leuven · Centre Hospitalier Regional CHR de la Citadelle, Liège · AZ Delta (H.-Hartziekenhuis Roeselare-Menen vzw (HHRM)) - Campus Wilgenstraat Roeselare, Roeselare · Algemeen Ziekenhuis Sint-Blasius (AZSB), Sint-Gillis-Dendermonde · ZOL Genk, Campus Sint-Jan, Waterschei-Zwartberg · Clinique Universitaire de Mont Godinne, Yvoir
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
AZORG, Aalst · Az St-Jan Brugge-Oostende A.V., Brugge · O.L.Vrouw van Troost, Dendermonde · Universitair Ziekenhuis Antwerpen, Edegem · Ziekenhuis Oost-Limburg, Genk · AZ Sint-Lucas & Volkskliniek, Gent · Universitair Ziekenhuis Gent, Gent · JESSA Ziekenhuis, Hasselt · UZ Leuven, Leuven · Centre Hospitalier Regional de la Citadelle, Liège · Algemeen Ziekenhuis Delta, Roeselare · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-20
NCT07298044
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
Trial Treatment · Phase 4 · Bayer
Az St-Jan Brugge-Oostende A.V., Bruges · Hôpital Erasme/Erasmus Ziekenhuis, Brussels
Registry updated 2026-10-15
NCT07235462
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Research · Bayer
Many locations, Multiple Locations
Registry updated 2026-10-08
NCT07172243
BE.Amycon Biobank & Data Registry UZ Leuven
Research · Universitaire Ziekenhuizen KU Leuven
UZ Leuven Gasthuisberg - cardiology, Leuven · UZ Leuven Gasthuisberg - hematology, Leuven
Registry updated 2026-09-25
NCT07116473
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
UZ Leuven, Leuven
Registry updated 2026-08-11
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
UZ Leuven, Leuven
Registry updated 2026-08-04
NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.
Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan, Bruges · Ziekenhuis Oost-Limburg - Campus Sint-Jan, Limbourg
Registry updated 2026-04-17
NCT05950867
Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.
Trial Treatment · Universitair Ziekenhuis Brussel
UZ Brussel, Jette
Registry updated 2025-07-22
NCT06894290
International Cardiac Amyloidosis Registry
Research · Leiden University Medical Center
AZ St.Jan, Bruges · UZ Antwerpen, Edegem
Registry updated 2025-03-25

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error